debt_leverage_profile
0.02x Total Debt / Equity (Conservative)
High
SEC-XBRL
interest_rate_sensitivity
Low direct sensitivity; minimal long-term debt on balance sheet, but rising rates compress valuation multiples for small-cap growth stocks like LGMK
Inferred
Agent_Inference
geopolitical_supply_exposure
Low intensity; China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
supply_chain_dependency
Taiwan/China semiconductor fabrication for IoT chips; Southeast Asia contract electronics assembly are top two chokepoints
Inferred
Agent_Inference
international_expansion_readiness
Predominantly US-revenue (~95%+); negligible sovereign currency devaluation exposure in international markets currently
Inferred
Agent_Inference
geographic_footprint
Nearly 100% US-domestic revenue; no material exposure to foreign currency devaluation risk in top international markets
Inferred
Agent_Inference
commodity_exposure_profile
Low intensity; commodities: Active Pharmaceutical Ingredients, Rare Earth Elements, Natural Gas (energy), Plastics/Resins, Ethanol, Packaging Materials; geopolitical: China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
vendor_lock_dependency_score
AT&T/Verizon cellular network dependency for device connectivity is effectively non-substitutable short-term; represents critical operational input
Inferred
Agent_Inference
business_model_type_primary
Moderate disruption; hardware devices could operate on-premise short-term, but monitoring platform continuity would require 60-90 day migration effort
Inferred
Agent_Inference
business_model_type_secondary
Secondary SaaS monitoring subscription layer would face service interruption; redundant cloud deployment not publicly confirmed, increasing migration risk
Inferred
Agent_Inference
switching_cost_profile
Moderate API coupling risk; proprietary monitoring platform integrates with third-party call centers and telecom APIs, limiting easy substitution
Inferred
Agent_Inference
howey_test_risk_index
Low Howey Test risk; revenue model is hardware sales plus monitoring subscriptions, not investment contracts or profit-sharing arrangements
Inferred
Agent_Inference
regulatory_burden_tier
Very High
Medium
GICS-regulatory-overlay-v1
data_sovereignty_risk
Moderate CCPA exposure due to health/location data from elderly users; GDPR exposure minimal given near-zero EU revenue
Inferred
Agent_Inference
antitrust_exposure_flag
Negligible antitrust risk; company holds less than 5% of personal emergency response system (PERS) market, far below regulatory thresholds
Inferred
Agent_Inference
regulatory_exposure_profile
Very High burden; regimes: FDA, CMS, HHS, HIPAA, EMA, OIG; Drug pricing legislation and approval delays directly compress revenue visibility.
Medium
GICS-regulatory-overlay-v1
revenue_model_type
Approximately 60-65% recurring monitoring subscription revenue; 35-40% transactional hardware device sales
Inferred
Agent_Inference
monetization_vector
Dual vector: one-time device hardware sale plus recurring monthly monitoring fee (~$25-40/month per subscriber)
Inferred
Agent_Inference
pricing_architecture
Vulnerable to Medicare/Medicaid reimbursement rate compression; consumer price elasticity limits upward repricing in cost-sensitive elderly demographic
Inferred
Agent_Inference
pricing_power_rating
Below average; commodity PERS hardware limits hardware pricing power; monitoring fees constrained by competitive alternatives and fixed-income customer base
Inferred
Agent_Inference
target_gross_margin_bracket
66.8% Gross Margin (Premium (>60%))
High
SEC-XBRL
churn_vulnerability_index
Low free-rider leakage; service requires paid subscription for monitoring functionality; however involuntary churn from subscriber mortality is structurally elevated
Inferred
Agent_Inference
headcount_cost_structure
Largely sublinear; monitoring infrastructure scales without proportional headcount addition; hardware fulfillment and customer service add modest linear cost
Inferred
Agent_Inference
marginal_cost_of_growth
Low marginal cost for subscription additions; primary growth costs are customer acquisition and device subsidy, not operational headcount expansion
Inferred
Agent_Inference
franchise_compliance_risk
Not applicable; company does not operate a franchise model
Inferred
Agent_Inference
customer_acquisition_metric
At 10x scale, CAC likely improves via channel partnerships (retail, insurers, Medicare Advantage plans); LTV/CAC ratio estimated 3-4x currently
Inferred
Agent_Inference
network_effect_present
No meaningful network effects; product utility is individual, not network-dependent; scale benefits are cost-side only, not demand-side
Inferred
Agent_Inference
asset_efficiency_ratio
-36.7% Return on Assets (Negative equity)
High
SEC-XBRL
recession_resistance_tier
High recession resistance; personal emergency response is healthcare-adjacent necessity for aging population, demand largely inelastic to economic cycles
Inferred
Agent_Inference
customer_segment_primary
Direct-to-consumer elderly adults (65+) and their adult caregiver family members represent primary segment; no single customer exceeds 5% of revenue
Inferred
Agent_Inference
customer_segment_secondary
Institutional buyers including assisted living facilities, home health agencies, and insurance/Medicare Advantage plan partners are secondary segment
Inferred
Agent_Inference
characteristic_occupations
["11-0000 Management Occupations", "13-0000 Business and Financial Operations Occupations", "15-0000 Computer and Mathematical Occupations", "19-0000 Life, Physical, and Social Science Occupations", "21-0000 Community and Social Service Occupations", "23-0000 Legal Occupations", "29-0000 Healthcare Practitioners and Technical Occupations", "31-0000 Healthcare Support Occupations", "41-0000 Sales and Related Occupations", "43-0000 Office and Administrative Support Occupations", "51-0000 Production Occupations"]
High
SOC-2018/GICS-overlay
agent_automatable_labor_share
0.32 (HIL — ~32% of characteristic roles agent-automatable)
Medium
SOC-2018 + agentic-exposure-v1
capital_expenditure_profile
0.6% CapEx / Revenue (Low-CapEx Asset-Light)
High
SEC-XBRL
sec_cik
0001566826
High
SEC-EDGAR
ticker
LGMK
High
SEC-EDGAR